Found: 19
Select item for more details and to access through your institution.
Receptor binding and mitogenic effects of insulin and insulinlike growth factors I and II for human myeloid leukemic cells.
- Published in:
- Journal of Cellular Physiology, 1987, v. 133, n. 2, p. 219, doi. 10.1002/jcp.1041330204
- By:
- Publication type:
- Article
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Multivariate analysis of factors associated with outcome of treatment for adults with acute myelogenous leukemia.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Myelodysplastic syndromes, thy name is heterogeneity.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 3, p. 381, doi. 10.1111/bjh.18649
- By:
- Publication type:
- Article
Shared and distinct mechanisms of UBA1 inactivation across different diseases.
- Published in:
- EMBO Journal, 2024, v. 43, n. 10, p. 1919, doi. 10.1038/s44318-024-00046-z
- By:
- Publication type:
- Article
Profiling myelodysplastic syndromes by mass cytometry demonstrates abnormal progenitor cell phenotype and differentiation.
- Published in:
- Cytometry. Part B, 2020, v. 98, n. 2, p. 131, doi. 10.1002/cyto.b.21860
- By:
- Publication type:
- Article
p53 immunohistochemistry as an ancillary tool for rapid assessment of residual disease in TP53-mutated acute myeloid leukemia and myelodysplastic syndromes.
- Published in:
- American Journal of Clinical Pathology, 2024, v. 162, n. 3, p. 269, doi. 10.1093/ajcp/aqae034
- By:
- Publication type:
- Article
Mesenchymal Stromal Cell Density Is Increased in Higher Grade Myelodysplastic Syndromes and Independently Predicts Survival.
- Published in:
- American Journal of Clinical Pathology, 2014, v. 142, n. 6, p. 795, doi. 10.1309/AJCP71OPHKOTLSUG
- By:
- Publication type:
- Article
Alteration of colony-stimulating factor output, endotoxemia, and granulopoiesis in cyclic neutropenia.
- Published in:
- American Journal of Hematology, 1976, v. 1, n. 4, p. 375, doi. 10.1002/ajh.2830010403
- By:
- Publication type:
- Article
Biologic Nature of the Myelodysplastic Syndromes.
- Published in:
- Acta Haematologica, 1987, v. 78, n. S1, p. 94, doi. 10.1159/000205911
- By:
- Publication type:
- Article
Correlative Patterns of Leukocyte Counts at Presentation and Relapse in Acute Myelogenous Leukemia<sup>1</sup>.
- Published in:
- Acta Haematologica, 1986, v. 75, n. 2, p. 79, doi. 10.1159/000206090
- By:
- Publication type:
- Article
Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 12, p. 809, doi. 10.1002/gcc.22292
- By:
- Publication type:
- Article
A Phase II intra-patient dose-escalation trial of weight-based darbepoetin alfa with or without granulocyte-colony stimulating factor in myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 1, p. 15, doi. 10.1002/ajh.21316
- By:
- Publication type:
- Article
International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: Impact of cytopenias on clinical outcomes in myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 10, p. 765, doi. 10.1002/ajh.21249
- By:
- Publication type:
- Article
Specific Plasma Autoantibody Reactivity in Myelodysplastic Syndromes.
- Published in:
- Scientific Reports, 2013, p. 1, doi. 10.1038/srep03311
- By:
- Publication type:
- Article
Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q).
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0491-2
- By:
- Publication type:
- Article
Current therapeutic approaches for patients with myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 2, p. 131, doi. 10.1111/j.1365-2141.2010.08226.x
- By:
- Publication type:
- Article